MedTrace Logo

A Food Effect Study With ZN-c5 in Healthy Post-Menopausal Subjects

NCT04561752 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-12-23

No results posted yet for this study

Summary

This is a single-center, randomized, open-label, two-period, 2-way crossover food effect study to determine the comparative bioavailability of ZN-c5 under fed and fasting conditions, following single-dose administration of ZN-c5 capsules (150mg).

Conditions

  • Healthy

Interventions

DRUG

ZN-c5

ZN-c5 is the study drug.

Sponsors & Collaborators

  • Zeno Alpha Inc.

    lead INDUSTRY

Principal Investigators

  • Dimitris Voliotis · Zeno Alpha Inc.

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-02
Primary Completion
2020-12-11
Completion
2020-12-16
FDA Drug
Yes

Countries

  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04561752 on ClinicalTrials.gov